Jon Richards
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- Immunology top 1%
- Immunotherapy and Immune Responses
Papers in
- Oncology 43
- CAR-T cell therapy research 26
- Cancer Immunotherapy and Biomarkers 13
- Cutaneous Melanoma Detection and Management 9
- Immunology 27
- Immunotherapy and Immune Responses 23
- Co-authors
- Marc S. Ernstoff (3 shared papers)John M. Kirkwood (8 shared papers)Lawrence E. Flaherty (5 shared papers)Joseph G. Ibrahim (2 shared papers)Theodore F. Logan (3 shared papers)David F. McDermott (6 shared papers)F. Stephen Hodi (6 shared papers)Jedd D. Wolchok (9 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Cancer (5 papers)Annals of Oncology (4 papers)Cancer Research (3 papers)Investigational New Drugs (2 papers)
- Partner nations
- United StatesBelgiumItaly
In The Last Decade
Jon Richards
81 papers receiving 4.2k citations
Jon Richards's Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 2.5k
- Immunology 1.5k
- Immunology and Allergy 143
- Genetics 245
- Molecular Biology 1.6k
Countries citing papers authored by Jon Richards
This map shows the geographic impact of Jon Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Richards more than expected).
Fields of papers citing papers by Jon Richards
This network shows the impact of papers produced by Jon Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Richards. The network helps show where Jon Richards may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon Richards, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial Hit paper breakdown → | 2012 | 867 |
| 2 | High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190 Hit paper breakdown → | 2000 | 705 |
| 3 | 2008 | 214 | |
| 4 | 1992 | 209 | |
| 5 | 2008 | 192 | |
| 6 | 2010 | 159 | |
| 7 | 2013 | 153 | |
| 8 | 1998 | 149 | |
| 9 | 2019 | 125 | |
| 10 | 1995 | 104 | |
| 11 | 1981 | 85 | |
| 12 | 1999 | 79 | |
| 13 | 2010 | 79 | |
| 14 | 2009 | 63 | |
| 15 | 2007 | 61 | |
| 16 | 2014 | 60 | |
| 17 | 2010 | 57 | |
| 18 | 1983 | 50 | |
| 19 | 1984 | 50 | |
| 20 | 2002 | 45 |
About Jon Richards
Jon Richards is a scholar working on Oncology, Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 84 papers that have together received 4.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (26 papers), Immunotherapy and Immune Responses (23 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Cancer Immunotherapy and Biomarkers (13 papers), Cutaneous Melanoma Detection and Management (9 papers), Melanoma and MAPK Pathways (9 papers), Virus-based gene therapy research (7 papers) and Cell Adhesion Molecules Research (6 papers). The work is most often cited by research in Oncology (2.5k citations), Immunology (1.5k citations), Immunology and Allergy (143 citations), Genetics (245 citations) and Molecular Biology (1.6k citations). Jon Richards has collaborated with scholars based in United States, Belgium and Italy. Frequent co-authors include Marc S. Ernstoff, John M. Kirkwood, Lawrence E. Flaherty, Joseph G. Ibrahim, Theodore F. Logan, David F. McDermott, F. Stephen Hodi, Jedd D. Wolchok, Mary Steele and Thomas J. Smith. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, Cancer Research and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.